Valuation (79%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 5.39 | 19.91 |
| PEG Ratio (TTM) | 0.40 | 2.03 |
| P/S Ratio (TTM) | 2.48 | 1.77 |
| P/B Ratio (TTM) | -0.43 | 3.32 |
| P/FCF Ratio (TTM) | 9.35 | 30.34 |
| Price to 5YR AVG Earnings Ratio | 2.65 | -130.07 |
| Price to 5YR AVG FCF Ratio | 12.65 | -92.04 |
Profitability (40%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 27.40% | 8.05% |
| ROE (TTM) | -9.13% | 13.34% |
| Net Profit Margin (TTM) | 14.28% | 7.67% |
| ROIC 5YR AVG | -88.84% | 12.36% |
Growth (90%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 154.99% | 37.99% | 15.86% |
| Revenue | 2.49% | 22.15% | 22.19% |
| Net Income | 174.77% | 19.80% | 6.41% |
| Cash Flow | 4.51% | 34.98% | 27.32% |
Health (39%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 2.79 | 3.03 |
| Quick Ratio (TTM) | 1.61 | 1.91 |
| D/E Ratio (TTM) | -0.45 | 0.61 |
| Interest Coverage (TTM) | 11.28 | 175.78 |
| Piotroski F-Score | 6 | 6 |
| Altman Z-Score | N/A | 5.49 |
| LTL to 5YR AVG FCF | 4.06 | -33.64 |
| Shares Outstanding Growth 5YR AVG | 13.96% | -0.36% |